BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25037619)

  • 1. Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca(2+) adenosine triphosphatase delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy.
    Katz MG; Fargnoli AS; Williams RD; Steuerwald NM; Isidro A; Ivanina AV; Sokolova IM; Bridges CR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1065-72, 1073e1-2; discussion1072-3. PubMed ID: 25037619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction.
    Swain JD; Fargnoli AS; Katz MG; Tomasulo CE; Sumaroka M; Richardville KC; Koch WJ; Rabinowitz JE; Bridges CR
    J Cardiovasc Transl Res; 2013 Apr; 6(2):253-62. PubMed ID: 23208013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure.
    Fargnoli AS; Katz MG; Yarnall C; Isidro A; Petrov M; Steuerwald N; Ghosh S; Richardville KC; Hillesheim R; Williams RD; Kohlbrenner E; Stedman HH; Hajjar RJ; Bridges CR
    Ann Thorac Surg; 2013 Aug; 96(2):586-95. PubMed ID: 23773730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation.
    Beeri R; Chaput M; Guerrero JL; Kawase Y; Yosefy C; Abedat S; Karakikes I; Morel C; Tisosky A; Sullivan S; Handschumacher MD; Gilon D; Vlahakes GJ; Hajjar RJ; Levine RA
    Circ Heart Fail; 2010 Sep; 3(5):627-34. PubMed ID: 20634484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression.
    Katz MG; Brandon-Warner E; Fargnoli AS; Williams RD; Kendle AP; Hajjar RJ; Schrum LW; Bridges CR
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1191-200.e3. PubMed ID: 26769537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve.
    Katz MG; Fargnoli AS; Swain JD; Tomasulo CE; Ciccarelli M; Huang ZM; Rabinowitz JE; Bridges CR
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):720-726.e3. PubMed ID: 22143102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling.
    Konkalmatt PR; Beyers RJ; O'Connor DM; Xu Y; Seaman ME; French BA
    Circ Cardiovasc Imaging; 2013 May; 6(3):478-86. PubMed ID: 23536266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction.
    Zhao Y; Li T; Wei X; Bianchi G; Hu J; Sanchez PG; Xu K; Zhang P; Pittenger MF; Wu ZJ; Griffith BP
    Stem Cells Transl Med; 2012 Sep; 1(9):685-95. PubMed ID: 23197875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo.
    White JD; Thesier DM; Swain JB; Katz MG; Tomasulo C; Henderson A; Wang L; Yarnall C; Fargnoli A; Sumaroka M; Isidro A; Petrov M; Holt D; Nolen-Walston R; Koch WJ; Stedman HH; Rabinowitz J; Bridges CR
    Gene Ther; 2011 Jun; 18(6):546-52. PubMed ID: 21228882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of genetic transfection on calcium cycling pathways mediated by double-stranded adeno-associated virus in postinfarction remodeling.
    Katz MG; Gubara SM; Hadas Y; Weber T; Kumar A; Eliyahu E; Bridges CR; Fargnoli AS
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1809-1819.e3. PubMed ID: 31679707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
    Fish KM; Ladage D; Kawase Y; Karakikes I; Jeong D; Ly H; Ishikawa K; Hadri L; Tilemann L; Muller-Ehmsen J; Samulski RJ; Kranias EG; Hajjar RJ
    Circ Heart Fail; 2013 Mar; 6(2):310-7. PubMed ID: 23271792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals.
    Byrne MJ; Power JM; Preovolos A; Mariani JA; Hajjar RJ; Kaye DM
    Gene Ther; 2008 Dec; 15(23):1550-7. PubMed ID: 18650850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model.
    Aguero J; Ishikawa K; Hadri L; Santos-Gallego CG; Fish KM; Kohlbrenner E; Hammoudi N; Kho C; Lee A; Ibáñez B; García-Alvarez A; Zsebo K; Maron BA; Plataki M; Fuster V; Leopold JA; Hajjar RJ
    J Am Coll Cardiol; 2016 May; 67(17):2032-46. PubMed ID: 27126531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.
    Kawase Y; Ly HQ; Prunier F; Lebeche D; Shi Y; Jin H; Hadri L; Yoneyama R; Hoshino K; Takewa Y; Sakata S; Peluso R; Zsebo K; Gwathmey JK; Tardif JC; Tanguay JF; Hajjar RJ
    J Am Coll Cardiol; 2008 Mar; 51(11):1112-9. PubMed ID: 18342232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spacial and Temporal Patterns of Gene Expression After Cardiac MEK1 Gene Transfer Improve Post-Infarction Remodeling Without Inducing Global Hypertrophy.
    Fan Y; Yang YL; Yeh CC; Mann MJ
    J Cell Biochem; 2017 Apr; 118(4):775-784. PubMed ID: 27639174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts.
    Shibata M; Takeshita D; Obata K; Mitsuyama S; Ito H; Zhang GX; Takaki M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2154-60. PubMed ID: 21856903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.
    Pleger ST; Shan C; Ksienzyk J; Bekeredjian R; Boekstegers P; Hinkel R; Schinkel S; Leuchs B; Ludwig J; Qiu G; Weber C; Raake P; Koch WJ; Katus HA; Müller OJ; Most P
    Sci Transl Med; 2011 Jul; 3(92):92ra64. PubMed ID: 21775667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling.
    Miyazaki Y; Ikeda Y; Shiraishi K; Fujimoto SN; Aoyama H; Yoshimura K; Inui M; Hoshijima M; Kasahara H; Aoki H; Matsuzaki M
    PLoS One; 2012; 7(4):e35875. PubMed ID: 22558250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases.
    Kawase Y; Hajjar RJ
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):554-65. PubMed ID: 18665137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
    Blom AS; Pilla JJ; Gorman RC; Gorman JH; Mukherjee R; Spinale FG; Acker MA
    Heart Fail Rev; 2005 Jun; 10(2):125-39. PubMed ID: 16258720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.